Literature DB >> 9427710

The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines.

S Kawamata1, H Sakaida, T Hori, M Maeda, T Uchiyama.   

Abstract

An immunosuppressant Rapamycin (Rap) has been reported to cause G1 arrest by inhibiting p70 S6 kinase and G1 cyclin/cdks kinase activities when added to quiescent cells with mitogens. However, antiproliferative effects of Rap on exponentially growing cells have been poorly investigated. We examined the intracellular events after the treatment of Rap in exponentially growing T cells and found that Rap upregulated a cdks inhibitor, p27Kip1 at both mRNA and protein levels in Rap-sensitive cells. Antiproliferative effect of Rap was mainly ascribed to the inhibition of cyclin E/cdk2 kinase activity through the formation of cyclin E/cdk2-p27Kip1 complex rather than inhibition of p70 S6 kinase activity. Furthermore, we showed that Rap-sensitive cells with elevated p27Kip1 expression lost sensitivity to Rap when antisense p27Kip1 was introduced, which indicates that the basal level of p27Kip1 is one of the limiting factors that determine the sensitivity to Rap in already cycling cells. These data suggest the presence of a putative threshold level of p27Kip1 at late G1 phase in already cycling cells. Rap may cause G1 arrest by upregulating the amount of p27Kip1 beyond the threshold in some Rap-sensitive cells that are exponentially growing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427710

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Antigen-specific dose-dependent system for the study of an inheritable and reversible phenotype in mouse CD4+ T cells.

Authors:  Eduardo J Firpo; Raymond K Kong; Qinghong Zhou; Alexander Y Rudensky; James M Roberts; B Robert Franza
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells.

Authors:  Pasithorn A Suwanabol; Stephen M Seedial; Fan Zhang; Xudong Shi; Yi Si; Bo Liu; K Craig Kent
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

3.  Rapamycin resistance is linked to defective regulation of Skp2.

Authors:  Hana Totary-Jain; Despina Sanoudou; Cula N Dautriche; Hillary Schneller; Lester Zambrana; Andrew R Marks
Journal:  Cancer Res       Date:  2012-02-06       Impact factor: 12.701

4.  Ikaros induces quiescence and T-cell differentiation in a leukemia cell line.

Authors:  Katie L Kathrein; Rachelle Lorenz; Angela Minniti Innes; Erin Griffiths; Susan Winandy
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 5.  Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Authors:  Sharon S McDaniel; Michael Wong
Journal:  Neurosci Lett       Date:  2011-02-24       Impact factor: 3.046

6.  Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells.

Authors:  Takayuki Hoshii; Atsuo Kasada; Tomoki Hatakeyama; Masashi Ohtani; Yuko Tadokoro; Kazuhito Naka; Tsuneo Ikenoue; Tomokatsu Ikawa; Hiroshi Kawamoto; Hans Joerg Fehling; Kimi Araki; Ken-ichi Yamamura; Satoshi Matsuda; Atsushi Hirao
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

Review 7.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

8.  Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy.

Authors:  Manikkam Suthanthiran; Minoru Hojo; Mary Maluccio; Daniel J Boffa; Fu L Luan
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

9.  mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability.

Authors:  Christine Mayer; Jian Zhao; Xuejun Yuan; Ingrid Grummt
Journal:  Genes Dev       Date:  2004-02-15       Impact factor: 11.361

10.  Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cells.

Authors:  Christian R Geest; Fried J Zwartkruis; Edo Vellenga; Paul J Coffer; Miranda Buitenhuis
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.